(firstQuint)A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease.

 This is a retrospective, non-interventional, observational study that will include consecutive participants diagnosed with Ulcerative Colitis (UC) or Crohn's Disease (CD) who started treatment with biologics between June 2011 and June 2013.

 This study will look at the impact of the co-morbidities on treatment response in IBD patients.

 The study will enroll approximately 400 patients: 200 UC patients and 200 CD patients.

 This multicenter trial will be conducted in Spain.

 Investigator will collect retrospective data in a single visit from participants who started biologic treatment between June 2011 and June 2013.

 Time since participants started biological treatment until study visit or until lack of treatment response or until treatment change will constitute the reference period for the study.

.

 A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease@highlight

The purpose of this study is to evaluate the impact of the co-morbidities profile on treatment response in inflammatory bowel disease (IBD) patients.

